Deal Watch: A Clean Skincare Brand at One Times Earnings

A clean beauty DTC brand hit the market this month. The numbers, on the surface, look like a fat pitch.

Two years old. Florida-based. $7.87M trailing twelve-month revenue. $768K in annual profit. 215,000+ customers acquired. 206,000+ emails owned. Registered trademarks, registered patents, a Recharge subscription engine. Asking $729,500.

That’s a 1.0x profit multiple. 0.1x revenue.

That number should make you stop scrolling.

A clean beauty brand with this kind of customer file does not normally trade at one times earnings. Here’s where the rest of the market is clearing right now:

This listing is asking 1.0x. A 75% discount to the smallest comparable category and a 90%+ discount to where strategics are paying for science-backed skincare.

When an asset prints that far below the curve, the right question isn’t “what a steal.” The right question is what the price is telling you about the trajectory.

Look at the lifetime numbers against the trailing year and a different picture emerges than the asking price implies.

The brand generated $10M+ in revenue in its first 17 months and $800K+ in cumulative profit. That averages roughly $588K per month in revenue at the launch sprint. The trailing twelve months delivered $7.87M in revenue and $768K in profit — averaging $656K per month.

Top line is roughly flat to slightly up against the launch surge. For a DTC brand two years post-launch, that isn’t a collapse. It’s deceleration from peak.

Margin tells a similar story. Lifetime profit-to-revenue is around 8%. TTM margin is 10%. The brand is making more per dollar of revenue today than it did during the launch sprint, not less.

So the headline isn’t a dying business. The headline is a brand that scaled fast, has stopped scaling, and is now running a lean, profitable steady-state at $7–8M with an improving margin.

That’s the bull case. The bear case lives in four places.

The subscription line is opaque. Current MRR is stated as $50,000+. Peak MRR is stated as $120,000+. The listing does not say when the peak occurred or how the line trended in between. It could be a launch-month spike that never repeated. It could be a sustained level the brand fell off. A buyer cannot tell from the document, which means a buyer has to ask. That gap goes at the top of the diligence list.

Margin is thin. 10% on a brand that owns its IP and runs asset-light is below where this category should clear. The science-backed brands getting premium multiples are operating at 30%+. A 10% margin is the messy middle.

Supply chain risk is live. Fulfillment routes through a China-based 3PL, which in 2026 means tariff exposure is an underwriting question, not an academic one.

SKU concentration. One hero SKU drives the majority of sales — the kind of concentration that makes a strategic acquirer pause and a tired founder discount aggressively to move on.

Beauty Independent called 2025 the “barbell” year: premiums went to brands with science-backed IP and 30%+ EBITDA margins, while everyone in the messy middle struggled to clear at any price. A 10%-margin DTC brand with a single hero SKU and China supply risk isn’t getting a Medik8 multiple. It’s getting whatever someone will pay to take the asset off the founder’s hands.

None of this kills the deal. It explains the price.

The buyer who wins this asset is not buying a growth story. They are buying a customer acquisition machine that someone else spent two years and seven figures of ad spend to build. 206,000 emails. 215,000 buyers in a file. Validated creative, validated funnels, validated unit economics at scale.

You cannot build that for $729,500. You cannot build that for three times $729,500.

What you can do is buy it and run a four-step operator playbook:

A buyer who lifts EBITDA margin from 10% to 25% on the same revenue base has, on paper, taken a 1.0x asset to a 4–6x asset without growing the top line a dollar.

This is what motivated supply looks like in DTC right now. Brands that scaled on cheap paid social in 2023–24 are hitting the wall on retention and CAC, and the founders who didn’t build durable moats are exiting at multiples nobody would have entertained eighteen months ago.

For an operator with a thesis and a stomach for the work, that’s not a problem. That’s the opportunity.

Subscribe to get the inside on more deals. Email me [email protected] to see more.